Latest new developments on Next-Generation Sequencing

Share Article

SMi’s Next-Generation Sequencing conference on 17th & 18th September 2012, in London focuses exclusively on the data interpretation and analytical challenges facing genomics and computational biology today. Whether working with microbial or human DNA, the latest developments to extract biological meaning from short-reads, oligonulceotide sequences or whole genome studies are showcased in this innovative conference. Featuring experts from the EBI, Wellcome Trust Sanger Institute, Merck, Pfizer and Janssen, join your peers at the forefront of translating genomics to targeted therapies.

News Image

SMi are delighted to confirm Elia Stupka, Co-Director and Head of Unit, Center for Translational Genomics and Bioinformatics, San Raffaele Scientific Institute, as a speaker at their forthcoming Next-Generation Sequencing conference.

Dr. Stupka’s pioneering work emphasises the genome as a comprehensive entity in health and disease, rather than specific fields such as genetics and gene expression per se. Through rigorous data analysis and interpretation, the role of genetics, epigenetics, gene expression and genome conformation is being elucidated to aid clinicians. Excitingly, his work goes beyond traditional case control studies to include familial cases of complex disease.

Dr. Stupka’s contribution consolidates a focus on data analysis and interpretation to develop improved therapies for human inherited and acquired diseases. Attending will enable you to:

  • Generate longer nucleic acid and oligonucleotide sequences of higher quality
  • Increase consensus accuracy and genome coverage
  • Maximise the alignment and assembly of NGS reads with reference sequences Enhance signal-to-noise measurements in real-time sequencing
  • Utilise exomics to elucidate gene families implicated in disease or pharmacogenetic effects
  • Improve mapping in repetitive regions when resequencing
  • Catalogue the transcriptomes of cells, tissues and pathogens
  • Perform quantitative applications more effectively with third generation platforms
  • Clarify analysis requirements prior to epigenomic studies

Visit http://www.smi-online.co.uk/goto/next-generationsequencing45.asp to secure your place now!

Alternatively, contact Alternatively Contact Fateja Begum on telephone +44 (0) 20 7827 6184 or email on fbegum(at)smi-online(dot)co(dot)uk.

About SMi Group
The SMi Group is a world leader in business to business information. With nearly two decades in the business, thousands of senior executives from blue chip companies have already benefitted from SMi’s highly targeted conferences, workshops and publications. For more information visit http://www.smi-online.co.uk/goto/next-generationsequencing45.asp.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Dale Butler
SMi Group Ltd
0207 827 6044
Email >
Follow us on
Visit website